CSIMarket
 


Nuo Therapeutics Inc   (NUOT)
Other Ticker:  
 
 

NUOT's Revenue Growth by Quarter and Year

Nuo Therapeutics Inc 's Revenue results by quarter and year




NUOT Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.07 0.03 0.04
III Quarter September 0.23 0.04 0.00 0.81
II Quarter June 0.12 0.00 0.06 0.26
I Quarter March 0.06 0.00 0.04 0.14
FY   0.41 0.11 0.13 1.25



NUOT Revenue third quarter 2023 Y/Y Growth Comment
Nuo Therapeutics Inc achieved in the third quarter 2023, above Company average Revenue surge of 480.6% year on year, to $ 0.23 millions.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 17 other companies have achieved higher Revenue growth. While Nuo Therapeutics Inc ' s Revenue doubling of 480.6% ranks overall at the positon no. 277 in the third quarter 2023.




NUOT Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 133.33 % -25 % -75 %
III Quarter September 480.6 % - - -
II Quarter June - - -76.92 % 62.5 %
I Quarter March - - -71.43 % -26.32 %
FY   - -15.38 % -89.6 % 257.14 %

Financial Statements
Nuo Therapeutics Inc 's third quarter 2023 Revenue $ 0.23 millions NUOT's Income Statement
Nuo Therapeutics Inc 's third quarter 2022 Revenue $ 0.04 millions Quarterly NUOT's Income Statement
New: More NUOT's historic Revenue Growth >>


NUOT Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 75 % - -95.06 %
III Quarter September 93.53 % - - 211.54 %
II Quarter June 100 % - 50 % 85.71 %
I Quarter March -14.29 % - 0 % -12.5 %
FY (Year on Year)   - -15.38 % -89.6 % 257.14 %




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #18
Healthcare Sector #100
Overall #277

Revenue Y/Y Growth Statistics
High Average Low
287.5 % 26.75 % -100 %
(Jun 30 2019)   (Dec 31 2021)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #18
Healthcare Sector #100
Overall #277
Revenue Y/Y Growth Statistics
High Average Low
287.5 % 26.75 % -100 %
(Jun 30 2019)   (Dec 31 2021)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Nuo Therapeutics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
3877.21 % 194.48 % -100 %
(Dec 31 2016)  


NUOT's III. Quarter Q/Q Revenue Comment
Nuo Therapeutics Inc achieved in the III. Quarter 2023 below company average Revenue jump of 93.53% quarter on quarter, to $ 0.23 millions.

III. Quarter 2023 NUOT's Revenue quarter on quarter growth were paradoxical, although lower than the average rise of 194.48 %, yet it presents real improvement compare to the % in the same quarter a year ago Nathaniel  Wilson, Medical Equipment & Supplies industry contributor mentioned.

Within Medical Equipment & Supplies industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Nuo Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 106.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #5
Healthcare Sector #59
Overall #106
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #5
Healthcare Sector #59
Overall #106
Revenue Q/Q Growth Statistics
High Average Low
3877.21 % 194.48 % -100 %
(Dec 31 2016)  


NUOT's III. Quarter Q/Q Revenue Comment
Nuo Therapeutics Inc achieved in the III. Quarter 2023 below company average Revenue jump of 93.53% quarter on quarter, to $ 0.23 millions.

III. Quarter 2023 Nuo Therapeutics Inc 's Revenue quarter on quarter growth appear to be paradoxical, albeit lower than the regular, yet it presents a quite recovery relative to the % in the III. Quarter 2022.

Within Medical Equipment & Supplies industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Nuo Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 106.


Nuo Therapeutics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 0.49 $ 0.29 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) 66.54 % - - - -
Seq. Revenue Growth (TTM) Overall Ranking # 325 # 0 # 0 # 0 # 0




Cumulative Revenue growth Comment
Nuo Therapeutics Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 480.6% year on year, to $ 0 millions if the fiscal year would have ended in Sep 30 2023.
Nuo Therapeutics Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Jun 30 2023. And, Nuo Therapeutics Inc realized the fastest Revenue growth, in Medical Equipment & Supplies industry.
But from the previous reporting period increase was slower at 66.54 % from $0.29 millions recorded in twelve months ending a quarter Jun 30 2023.
In spite of, it was validation of positive momentum, as the usual Q/Q TTM growth lays at 26.75%.

Nuo Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
287.5 %
26.75 %
-100 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 111
S&P 500 # 325
Cumulative Revenue growth Comment
Nuo Therapeutics Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 480.6% year on year, to $ 0 millions if the fiscal year would have ended in Sep 30 2023.
Nuo Therapeutics Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Jun 30 2023. And, Nuo Therapeutics Inc realized the fastest Revenue growth, in Medical Equipment & Supplies industry.
But from twelve months ended Jun 30 2023 growth rate was less at 66.54 % from $0.29 millions recorded in twelve months ending a quarter before Nathaniel  Wilson added on.
Still this was evidence of positive momentum, as the usual sequential advancement lays at 26.75%.
The growth was even higher from twelve months ended Jun 30 2023 showed at 66.54 % rise from $0.29 millions in the period from Jun 30 2023 to Sep 30 2022.

Nuo Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
287.5 %
26.75 %
-100 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 111
S&P 500 # 325




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NUOT's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NUOT's Competitors
Revenue Growth for Nuo Therapeutics Inc 's Suppliers
Revenue Growth for NUOT's Customers

You may also want to know
NUOT's Annual Growth Rates NUOT's Profitability Ratios NUOT's Asset Turnover Ratio NUOT's Dividend Growth
NUOT's Roe NUOT's Valuation Ratios NUOT's Financial Strength Ratios NUOT's Dividend Payout Ratio
NUOT's Roa NUOT's Inventory Turnover Ratio NUOT's Growth Rates NUOT's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Akili Inc 756.10%$ 756.098 millions
Lyell Immunopharma Inc 733.33%$ 733.333 millions
Abeona Therapeutics Inc 723.61%$ 723.611 millions
Mei Pharma Inc 647.96%$ 647.961 millions
Immunogen inc 637.72%$ 637.724 millions
Axim Biotechnologies Inc 629.15%$ 629.148 millions
Caribou Biosciences Inc 616.38%$ 616.379 millions
Spectral Ai Inc 554.49%$ 554.490 millions
Zymeworks Inc 527.37%$ 527.366 millions
Nuo Therapeutics Inc 507.17%$ 507.166 millions
U S Physical Therapy Inc460.06%$ 460.062 millions
Rhythm Pharmaceuticals inc 425.30%$ 425.303 millions
Volitionrx Limited405.02%$ 405.016 millions
Apellis Pharmaceuticals Inc 400.54%$ 400.540 millions
Rewalk Robotics Ltd 396.95%$ 396.953 millions
Bioadaptives Inc 368.95%$ 368.954 millions
Tenon Medical Inc 353.85%$ 353.846 millions
Invo Bioscience Inc 314.28%$ 314.283 millions
Capricor Therapeutics inc 288.66%$ 288.662 millions
Celldex Therapeutics inc 272.73%$ 272.727 millions
Pieris Pharmaceuticals Inc 263.50%$ 263.501 millions
Atai Life Sciences N v 262.50%$ 262.500 millions
Axsome Therapeutics Inc 243.08%$ 243.077 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com